Covid19

COVID-19 variant boosters won't need new clinical trials for clearance, FDA says

The FDA will rely on data from clinical trials of COVID-19 vaccine boosters against the BA.1 version of the omicron variant to evaluate boosters …

Read more at www.theverge.com

Show More

Related Articles

Back to top button